<bill session="115" type="s" number="2453" updated="2019-04-18T16:41:43Z">
  <state datetime="2018-02-27">REFERRED</state>
  <status>
    <introduced datetime="2018-02-27"/>
  </status>
  <introduced datetime="2018-02-27"/>
  <titles>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to require hospitals to provide the Secretary with information on the hospital's acquisition costs for 340B drugs and the total revenues received by the hospital for such drugs.</title>
    <title type="short" as="introduced">Ensuring the Value of the 340B Program Act of 2018</title>
    <title type="short" as="introduced">Ensuring the Value of the 340B Program Act of 2018</title>
    <title type="display">Ensuring the Value of the 340B Program Act of 2018</title>
  </titles>
  <sponsor bioguide_id="G000386"/>
  <cosponsors/>
  <actions>
    <action datetime="2018-02-27">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-02-27" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2018-02-27T05:00:00Z" status="Introduced in Senate">Ensuring the Value of the 340B Program Act of 2018

This bill requires a hospital participating in the 340B drug discount program to include, in any&#160;Medicare cost report to the Centers for Medicare &amp; Medicaid Services, information on: (1)&#160;the aggregate acquisition costs of the hospital for drugs acquired under the program; and (2)&#160;the&#160;aggregate revenues the hospital received from all payors for&#160;such drugs, disaggregated by insurance status.</summary>
  <committee-reports/>
</bill>
